![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Orchid to Launch Cephalosporin Generics in U.S. by July
Orchid to Launch Cephalosporin Generics in U.S. by July
May 2, 2005
The Chennai-based Orchid Chemicals & Pharmaceuticals Ltd, with its ongoing thrust to penetrate into the U.S. generics market, is expecting a significant growth in its export business from the first half the current financial year. The company, which has scheduled to enter the U.S. market with its cephalosporin generics by July 2005, would also focus on other regulated markets for export of generics in the current financial year.
Pharmabiz (http://www.pharmabiz.com/article/detnews.asp?articleid=27380)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct